Abstract
Neuroophthalmic manifestations are very rare in corona virus disease-19 (COVID-19) infection. Only few reports have been published till date describing COVID-19-associated neuroophthalmic manifestations. We, hereby, present a series of three cases who developed optic neuritis during the recovery period from COVID-19 infection. Among the three patients, demyelinating lesions were identified in two cases, while another case was associated with serum antibodies against myelin oligodendrocyte glycoprotein. All three patients received intravenous methylprednisolone followed by oral steroids according to the Optic Neuritis Treatment Trail ptotocol. Vision recovery was noted in all three patients, which was maintained at 2 months of the last follow up visit.
Keywords: COVID-19; myelin oligodendrocyte glycoprotein; neuroophthalmic manifestation; optic neuritis.
【저자키워드】 COVID-19, Optic neuritis, myelin oligodendrocyte glycoprotein, neuroophthalmic manifestation, 【초록키워드】 Infection, virus, COVID-19 infection, Patient, Manifestations, glycoprotein, serum antibody, patients, manifestation, lesion, vision, intravenous methylprednisolone, Neuritis, Optic, oral steroid, 【제목키워드】 case sery,